Panagora Asset Management Inc. lowered its position in Humana Inc (NYSE:HUM) by 89.5% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 4,681 shares of the insurance provider’s stock after selling 39,950 shares during the period. Panagora Asset Management Inc.’s holdings in Humana were worth $1,242,000 at the end of the most recent quarter.
Other hedge funds have also recently made changes to their positions in the company. Whittier Trust Co. purchased a new position in shares of Humana during the 2nd quarter worth $27,000. Next Capital Management LLC purchased a new position in shares of Humana during the 2nd quarter worth $27,000. Advantage Investment Management LLC raised its holdings in shares of Humana by 287.1% during the 2nd quarter. Advantage Investment Management LLC now owns 120 shares of the insurance provider’s stock worth $32,000 after acquiring an additional 89 shares during the period. Coastal Investment Advisors Inc. raised its holdings in shares of Humana by 1,110.0% during the 2nd quarter. Coastal Investment Advisors Inc. now owns 121 shares of the insurance provider’s stock worth $33,000 after acquiring an additional 111 shares during the period. Finally, Harel Insurance Investments & Financial Services Ltd. purchased a new position in shares of Humana during the 2nd quarter worth $36,000. Institutional investors own 92.90% of the company’s stock.
Several research analysts have recently commented on HUM shares. JPMorgan Chase & Co. lifted their price target on Humana from $288.00 to $322.00 and gave the stock an “overweight” rating in a report on Thursday, August 1st. Cantor Fitzgerald upgraded Humana from a “neutral” rating to an “overweight” rating and lifted their price target for the stock from $300.00 to $345.00 in a report on Monday, August 12th. UBS Group lifted their price target on Humana from $266.00 to $317.00 and gave the stock a “neutral” rating in a report on Thursday, August 1st. SunTrust Banks lifted their price target on Humana to $340.00 and gave the stock a “hold” rating in a report on Thursday, August 1st. Finally, Deutsche Bank started coverage on Humana in a report on Thursday. They set a “hold” rating on the stock. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and fourteen have assigned a buy rating to the stock. Humana has a consensus rating of “Buy” and an average price target of $341.95.
Shares of NYSE:HUM traded down $1.33 during midday trading on Thursday, reaching $275.48. 334,388 shares of the company’s stock were exchanged, compared to its average volume of 1,267,515. The firm’s 50 day simple moving average is $287.14 and its two-hundred day simple moving average is $269.38. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.75 and a quick ratio of 1.75. The stock has a market cap of $37.24 billion, a price-to-earnings ratio of 18.93, a P/E/G ratio of 1.19 and a beta of 0.84. Humana Inc has a fifty-two week low of $225.65 and a fifty-two week high of $355.88.
Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.24 by $0.81. The firm had revenue of $16.25 billion during the quarter, compared to the consensus estimate of $15.88 billion. Humana had a return on equity of 22.47% and a net margin of 4.13%. The company’s quarterly revenue was up 13.9% on a year-over-year basis. During the same period last year, the company earned $3.96 EPS. Equities research analysts predict that Humana Inc will post 17.63 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be given a dividend of $0.55 per share. This represents a $2.20 dividend on an annualized basis and a dividend yield of 0.80%. The ex-dividend date of this dividend is Friday, September 27th. Humana’s payout ratio is 15.12%.
In related news, insider Brian P. Leclaire sold 7,239 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $289.70, for a total transaction of $2,097,138.30. Following the completion of the sale, the insider now directly owns 12,994 shares of the company’s stock, valued at approximately $3,764,361.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.54% of the stock is currently owned by company insiders.
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Recommended Story: Diluted Earnings Per Share
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.